Targeting p38γ synergistically enhances sorafenib-induced cytotoxicity in hepatocellular carcinoma

被引：0
|
作者：
Chen Huang [1 ]
Chenliang Zhang [2 ]
Jiajin Li [1 ]
Yichun Duan [2 ]
Qiulin Tang [3 ]
Feng Bi [2 ]
机构：
[1] West China Hospital,Division of Abdominal Tumor Multimodality Treatment, Cancer Center and Laboratory of Molecular Targeted Therapy in Oncology
[2] Sichuan University,Division of Abdominal Tumor Multimodality Treatment
[3] West China Hospital,undefined
[4] Sichuan University,undefined
[5] Sichuan University,undefined
[6] West China Hospital of Sichuan University,undefined
来源：
Cell Biology and Toxicology | / 41卷 / 1期
关键词：
Hepatocellular carcinoma; Sorafenib; P38γ; Autophagy; Cell drug resistance;
D O I：
10.1007/s10565-024-09979-x
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Sorafenib-induced severe urticaria in a patient with hepatocellular cancer
    Musri, Fatma Yalcin
    Mutlu, Hasan
    Salim, Derya Kivrak
    Eryilmaz, Melek Karakurt
    Unal, Betul
    Tural, Deniz
    Coskun, Hasan Senol
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2016, 22 (02) : 350 - 353
  • [22] TGFβ sensitizes hepatocellular carcinoma cells to growth factors, preventing sorafenib-induced apoptosis
    Ungerleider, Nathan
    Han, Chang
    Wu, Tong
    CANCER RESEARCH, 2015, 75
  • [23] Macropinocytosis is an alternative pathway of cysteine acquisition and mitigates sorafenib-induced ferroptosis in hepatocellular carcinoma
    Jun-Kyu Byun
    Seunghyeong Lee
    Gil Won Kang
    Yu Rim Lee
    Soo Young Park
    Im-Sook Song
    Jae Won Yun
    Jaebon Lee
    Yeon-Kyung Choi
    Keun-Gyu Park
    Journal of Experimental & Clinical Cancer Research, 41
  • [24] Macropinocytosis is an alternative pathway of cysteine acquisition and mitigates sorafenib-induced ferroptosis in hepatocellular carcinoma
    Byun, Jun-Kyu
    Lee, Seunghyeong
    Kang, Gil Won
    Lee, Yu Rim
    Park, Soo Young
    Song, Im-Sook
    Yun, Jae Won
    Lee, Jaebon
    Choi, Yeon-Kyung
    Park, Keun-Gyu
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2022, 41 (01)
  • [25] Amentoflavone enhances sorafenib-induced apoptosis through extrinsic and intrinsic pathways in sorafenib-resistant hepatocellular carcinoma SK-Hep1 cells in vitro
    Chen, Wei-Lung
    Hsieh, Chia-Ling
    Chen, Jiann-Hwa
    Huang, Chih-Sheng
    Chen, Wei-Ting
    Kuo, Yu-Cheng
    Chen, Cheng-Yu
    Hsu, Fei-Ting
    ONCOLOGY LETTERS, 2017, 14 (03) : 3229 - 3234
  • [26] CYCLIN E1 SUPPRESSION CONTRIBUTES TO SORAFENIB-INDUCED APOPTOSIS IN HEPATOCELLULAR CARCINOMA (HCC)
    Hsu, C.
    Ou, D.
    Cheng, Y.
    Lin, Y.
    Chang, Y.
    Yeh, K.
    Cheng, A.
    ANNALS OF ONCOLOGY, 2012, 23 : 253 - 253
  • [27] Annonaceous Acetogenins Synergistically Inhibit Hepatocellular Carcinoma with Sorafenib
    Li, Rong-Sheng
    Li, Ling-Yun
    Zhu, Xiao-Feng
    Li, Xian
    Wang, Chun-Yan
    Qiu, Shuang-Jian
    Zhou, Jian
    Fan, Jia
    Hu, Bo
    Mu, Qing
    JOURNAL OF NATURAL PRODUCTS, 2024, 87 (01): : 14 - 27
  • [28] Sorafenib-induced Acute on Chronic Liver Failure in a Patient with Hepatocellular Carcinoma After Microwave Ablation
    Malik, Anam Naveed
    Din, Asim Tameez Ud
    Chaudhary, Farooq Mohyud Din
    Quratulain, F. N. U.
    Siddiqui, Khaleeq H.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (07)
  • [29] CISD2 Promotes Resistance to Sorafenib-Induced Ferroptosis by Regulating Autophagy in Hepatocellular Carcinoma
    Li, Bowen
    Wei, Shibo
    Yang, Liang
    Peng, Xueqiang
    Ma, Yingbo
    Wu, Bo
    Fan, Qing
    Yang, Shuo
    Li, Xinyu
    Jin, Hongyuan
    Tang, Shilei
    Huang, Mingyao
    Li, Hangyu
    Liu, Jingang
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [30] Phosphorylated p38 and JNK MAPK proteins in hepatocellular carcinoma
    Wang, Shen-Nien
    Lee, King-Teh
    Tsai, Chia-Jung
    Chen, Yu-Jie
    Yeh, Yao-Tsung
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2012, 42 (12) : 1295 - 1301
12345